School-based prevention of acute rheumatic fever: A group randomized trial in New Zealand

Pediatric Infectious Disease Journal

Volumn 28, Issue 9, 2009, Pages 787-794

  Lennon, Diana ^a   Stewart, Joanna ^a   Farrell, Elizabeth ^b   Palmer, Anne ^b   Mason, Henare ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b Division of Medicine Emergency and Integrated Care   (New Zealand)

Author keywords

Oral penicillin; Rheumatic fever; School program; Streptococcal pharyngitis

Indexed keywords

BENZATHINE PENICILLIN; ERYTHROMYCIN ESTOLATE; PENICILLIN G;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENDEMIC DISEASE; GENERAL PRACTICE; GROUP A STREPTOCOCCAL INFECTION; HEALTH CARE ACCESS; HEALTH PROGRAM; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; NEW ZEALAND; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATIC FEVER; RISK REDUCTION; SCHOOL CHILD; SORE THROAT; STREPTOCOCCAL PHARYNGITIS; THROAT CULTURE;

EID: 70249121835     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181a282be     Document Type: Article

References (48)

1. World Health Organization. The Current Evidence for the Burden of Group A Streptococcal Diseases. Geneva: Switzerland: WHO; 2005. WHO/FCH/ CAH/05.07 WHO/IVB/05.12:60.
2. Cherry DK, Woodwell DA. National Ambulatory Medical Care Survey: 2000 summary. Adv Data. 2002:1-32.
3. Wood H, Feinstein A, Taranta A, et al. Rheumatic Fever in Children and Adolescents: a long-term epidemiologic study of subsequent prophylaxis, streptococcal infections, and clinical sequelae III. Comparative effectiveness of three prophylaxis regimens in preventing streptococcal infections and rheumatic recurrences. Ann Intern Med. 1964;60(suppl):31-45.
4. Thornley C, McNichols A, Baker M, et al. Rheumatic fever registers in New Zealand. NZ Public Health Rep. 2001;8:41-44. (Pubitemid 32799097)
5. Denny F, Wannamaker L, Brink W, et al. Prevention of Rheumatic Fever: treatment of the preceding streptococcic infection. JAMA. 1950;143:151-153.
6. Robertson KA, Volmink JA, Mayosi BM. Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis. BMC Cardiovasc Disord. 2005;5:1-9.
7. Siegel A, Johnson E, Stollerman G. Controlled studies of streptococcal pharngitis in a pediatric population. N Engl J Med. 1961;265:559-566.
8. Phibbs BP. Streptococcal control in school children. Is it worthwhile? Minn Med. 1975;58:607-610.
9. Coulehan J, Grant S, Reisinger K, et al. Acute rheumatic fever and rheumatic heart disease on the Navajo reservation, 1962-1977. Public Health Rep. 1980;95:62-68.
10. Chun LT, Reddy V, Rhoads GG. Occurrence and prevention of rheumatic fever among ethnic groups of Hawaii. Am J Dis Child. 1984;138:476-478.
11. Gordis L. Effectiveness of comprehensive-care programs in preventing rheumatic fever. N Engl J Med. 1973;289:331-335.
12. Bisno AL, Gerber MA, Gwaltney JM Jr, et al. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin Infect Dis. 2002;35:113-125.
13. Antibiotics and sore throat. Lancet. 1957;272:1128-1130.
14. Veasy L, Tani L, Hill H. Persistence of acute rheumatic fever in the intermountain area of the United States. J Pediatr. 1994;124:9-16.
15. Carapetis J, Wolff D, Currie B. Acute rheumatic fever and rheumatic heart disease in the top end of Australia?s Northern Territory. Med J Aust. 1996;164:146-149.
16. Lennon D, Martin D, Wong E, et al. Longitudinal study of poststreptococcal disease in Auckland; rheumatic fever, glomerulonephritis, epidemiology and M typing 1981-1986. N Z Med J. 1988;101:396-398.
17. Kurahara D, Tokuda A, Grandinetti A, et al. Ethnic differences in risk for pediatric rheumatic illness in a culturally diverse population. J Rheumatol. 2002;29:379-383.
18. Miyake CY, Gauvreau K, Tani LY, et al. Characteristics of children discharged from hospitals in the United States in 2000 with the diagnosis of acute rheumatic fever. Pediatrics. 2007;120:503-508.
19. Lennon D. Rheumatic fever, a preventable disease? The New Zealand Experience in streptococci and streptococcal disease. In: Proceedings of the 14th Lancefield International Symposium on Streptococci and Streptococ-cal Diseases; 2000; Porirua, New Zealand.
20. Hefford M, Crampton P, Foley J. Reducing health disparities through primary care reform: the New Zealand experiment. Health Policy. 2005; 72:9-23.
21. Martin DR. Laboratory evaluation of streptococci. In: Stevens D, Kaplan EL, eds. Streptococcal Infections: Clinical Aspects, Microbiology, and Molecular Pathogenesis. New York, NY: Oxford University Press; 2000: 266-279.
22. Rutstein DD, Bauer W, Dorfman A, et al. Jones Criteria (modified) for guidance in the diagnosis of rheumatic fever: report of the committee on standards and criteria for programs of care. Circulation. 1956;13:617-620.
23. Stollerman G, Markowitz M, Taranta A, et al. Jones criteria (revised) for guidance in the diagnosis of rheumatic fever. Circulation. 1965;32:664-668.
24. Wilson NJ, Neutze JM. Echocardiographic diagnosis of subclinical carditis in acute rheumatic fever. Int J Cardiol. 1995;50:1-6.
25. Special Writing Group of the Committee on Rheumatic Fever and Kawasaki Disease of the Council on Cardiovascular Disease in the young of the American Heart Foundation. Guideline for the diagnosis of rheumatic fever. Jones criteria 1992 update. JAMA. 1992;268:2069-2073.
26. Catanzaro F, Rammelkamp C, Chamovitz R. Prevention of rheumatic fever by treatment of streptococcal infections. II: factors responsible for failures. N Engl J Med. 1958;259:51-57.
27. Rammelkamp CH Jr, Stolzer BL. The latent period before the onset of acute rheumatic fever. Yale J Biol Med. 1961;34:386-398.
28. Lennon D, Kerdemelidis M, Arroll B, et al. Meta-analysis of trials of streptococcal throat treatment programs to prevent rheumatic fever. Pedi-act Infect Dis. J. 2009; 28: e259-e264.
29. Dingle JH, Badger GF, Jordan WS. Illness in the Home: A Study of 25,000 Illnesses in a Group of Cleveland Families. Cleveland, OH: Press of Western Reserve University; 1964:97-117.
30. Shulman S, Tanz RR, Gerber MA. Streptococcal pharyngitis. In: Stevens DL, Kaplan EL, eds. Streptococcal Infections. New York, NY: Oxford University Press; 2000.
31. Ezike EN, Rongkavilit C, Fairfax MR, et al. Effect of using 2 throat swabs vs. 1 throat swab on detection of group A streptococcus by a rapid antigen detection test. Arch Pediatr Adolesc Med. 2005;159:486-490.
32. Lanna CC, Tonelli E, Barros MV, et al. Subclinical rheumatic valvitis: a long-term follow-up. Cardiol Young. 2003;13:431-438.
33. McNeil SA, Halperin SA, Langley JM, et al. Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers. Clin Infect Dis. 2005;41:1114-1122.
34. Martin D, Voss L, Walker S, et al. Acute rheumatic fever in Auckland, New Zealand: spectrum of associated group A streptococci different from expected. Pediatr Infect Dis J. 1994;13:264-269.
35. Dey N, McMillan DJ, Yarwood PJ, et al. High diversity of group AStrep-tococcal emm types in an Indian community: the need to tailor multivalent vaccines. Clin Infect Dis. 2005;40:46-51.
36. Pruksakorn S, Sittisombut N, Phornphutkul C, et al. Epidemiological analysis of non-M-Typeable group A streptococcus isolates from a Thai Population in northern Thailand. J Clin Microbiol. 2000;38:1250-1254.
37. Sagar V, Bakshi DK, Nandi S, et al. Molecular heterogeneity among north Indian isolates of group A streptococcus. Lett Appl Microbiol. 2004;39: 84-88.
38. Bisno A, Rubin FA, Cleary P, et al. Prospects for group A streptococcal vaccine: rationale, feasibility, and obstacles: report of a National Institute of Allergy and Infectious Diseases Workshop. Clin Infect Dis. 2005;41:1150-1156.
39. Bisno AL, Pearce IA, Wall HP, et al. Contrasting epidemiology of acute rheumatic fever and acute glomerulonephritis. N Engl J Med. 1970;283: 561-565.
40. Potter E, Svartman M, Poon-King T, et al. The families of patients with acute rheumatic fever or glomerlonephritis in Trinidad. Am J Epidemiol. 1977;106:130-138.
41. Stollerman G. Rheumatic fever in the 21st century. Clin Infect Dis. 2001;33:806-814.
42. Ferrieri P, Dajani AS, Wannamaker LW, et al. Natural history of impetigo. Part I: site sequence of acquisition and familial patterns of spread of cutaneous streptococci. J Clin Invest. 1972;51:2851-2862.
43. Moore PS, Hierholzer J, DeWitt W, et al. Respiratory viruses and mycoplasma as cofactors for epidemic group A meningococcal meningitis [comment]. JAMA. 1990;264:1271-1275.
44. Lennon D. Feigin and Cherry textbook of pediatric infectious diseases. In: Feigin RD, Cherry J, Demmler GJ, et al, eds. Textbook of Pediatric Infectious Diseases. 5th ed. Philadelphia, PA: Saunders; 2004:413-426.
45. Craig E, Jackson C, Han DY, et al. Monitoring the Health of New Zealand Children and Young People: Indicator Handbook. Auckland, New Zealand: Paediatric Society of New Zealand, New Zealand Child and Youth Epidemiology Service; 2007:276.
46. Iyengar SD, Grover A, Kumar R, et al. Participation of health workers, school teachers and pupils in the control of rheumatic fever: evaluation of a training programme. Indian Pediatr. 1992;29:875-881.
47. Centor RM, Witherspoon JM, Dalton HP, et al. The diagnosis of strep throat in adults in the emergency room. Med Decis Making. 1981;1:239-246.
48. McIsaac WJ, Kellner JD, Aufricht P, et al. Empirical validation of guidelines for the management of pharyngitis in children and adults. JAMA. 2004;291:1587-1595